Optimizerx Corp 8-K Summary: Stockholder Voting Results
Business Context and Reporting Period
This Form 8-K reports the results of the 2025 Annual Meeting of Stockholders held on June 11, 2025. The company, OptimizeRx Corporation (trading symbol OPRX on The Nasdaq Capital Market), is incorporated in Nevada. As of the record date of April 29, 2025, there were 18,493,447 shares of common stock issued and outstanding entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Outcomes
Stockholders voted on three proposals. The results were as follows:
- Proposal 1: Election of Directors. All five nominees were elected. Significant broker non-votes (2,874,955) were recorded for each nominee.
- Lynn O'Connor Vos: 7,678,993 For; 5,380,016 Withheld.
- Catherine Klema: 11,050,447 For; 2,008,562 Withheld.
- James Lang: 8,291,707 For; 4,767,302 Withheld.
- Patrick Spangler: 7,413,854 For; 5,645,155 Withheld.
- Gregory D. Wasson: 8,809,348 For; 4,249,661 Withheld.
- Proposal 2: Advisory Vote on Executive Compensation. The proposal was approved.
- Votes in Favor: 5,443,720
- Votes Against: 3,857,653
- Abstain: 3,757,636
- Broker Non-Votes: 2,874,955
- Proposal 3: Ratification of Independent Auditor. UHY LLP was ratified as the independent registered public accounting firm.
- Votes in Favor: 15,162,244
- Votes Against: 745,489
- Abstain: 26,231
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the total number of shares entitled to vote (18,493,447) against the sum of votes cast, withheld, and broker non-votes to confirm participation rates.
- Note the high volume of broker non-votes (2,874,955) on director elections and the executive compensation vote, indicating a significant portion of shares were held by brokers without discretionary voting power.
- Confirm the term expiration for the newly elected directors, which is set for the next annual meeting of stockholders.
- Verify the fiscal year for which UHY LLP was ratified; the text states "2022 fiscal year" in the voting results section but "2025 fiscal year" in the proposal description, suggesting a potential clerical error in the filing text.